1-4 of 4
Ulrike B. Graubner
Close
Sort by
Journal Articles

Expression of the outcome predictor in acute leukemia 1 (OPAL1) gene is not an independent prognostic factor in patients treated according to COALL or St Jude protocols

Clinical Trials & Observations
Amy Holleman, Monique L. den Boer, Meyling H. Cheok, Karin M. Kazemier, Deqing Pei, James R. Downing, Gritta E. Janka-Schaub, Ulrich Göbel, Ulrike B. Graubner, Ching-Hon Pui, William E. Evans, Rob Pieters
Journal: Blood
Blood (2006) 108 (6): 1984–1990.
https://doi.org/10.1182/blood-2006-04-015990
Published: 2006
Journal Articles

The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia

Clinical Trials & Observations
Amy Holleman, Monique L. den Boer, Renée X. de Menezes, Meyling H. Cheok, Cheng Cheng, Karin M. Kazemier, Gritta E. Janka-Schaub, Ulrich Göbel, Ulrike B. Graubner, William E. Evans, Rob Pieters
Journal: Blood
Blood (2006) 107 (2): 769–776.
https://doi.org/10.1182/blood-2005-07-2930
Published: 2006
Includes: Supplemental data
Journal Articles

Germ-Line Genetic Variations in TP53 and Risk for Pediatric Acute Lymphoblastic Leukemia.

Toralf Bernig, MD, Laurie Burdette, PhD, Thomas Lehrnbecher, MD, Ulrike B. Graubner, MD, Monique L. den Boer, MD, Rob Pieters, MD, Gritta E. Janka-Schaub, MD, Stephen J. Chanock, MD
Journal: Blood
Blood (2004) 104 (11): 1890.
https://doi.org/10.1182/blood.V104.11.1890.1890
Published: 2004
Journal Articles

Thioguanine offers no advantage over mercaptopurine in maintenance treatment of childhood ALL: results of the randomized trial COALL-92

Clinical Trials & Observations
Dörthe O. Harms, Ulrich Göbel, Hans J. Spaar, Ulrike B. Graubner, Norbert Jorch, Peter Gutjahr, Gritta E. Janka-Schaub, for the COALL Study Group
Journal: Blood
Blood (2003) 102 (8): 2736–2740.
https://doi.org/10.1182/blood-2002-08-2372
Published: 2003